Skip to content
akaturk Academic measurement
Search

Article detail · 2023 · article

Evaluation of the relationship between blood cell markers and inflammation, disease activity, and general health status in ankylosing spondylitis

YÖKSİS OpenAlex Open access · diamond Top 10%
Year2023
Citations20OpenAlex
Citations21Semantic Scholar · 2 influential
Percentile%94.1
FWCI3.641.00 = world average
Scopus (SJR)Q3
WoS (JCR)Q2

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueRevista da Associacao Medica Brasileira
  • Catalog match (ISSN)Revista da Associacao Medica Brasileira
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

OBJECTIVE: The aim of this study was to assess the relation of systemic immune inflammation index, systemic inflammation response index, and systemic inflammation aggregate index with disease activity, functional status, and general health status in ankylosing spondylitis. METHODS: Patients with ankylosing spondylitis and healthy volunteers were included in this cross-sectional study. Demographic data; disease activity measurements such as the Bath Ankylosing Spondylitis Disease Activity Index, the Ankylosing Spondylitis Disease Activity Score with C-reactive protein, and the Ankylosing Spondylitis Disease Activity Score with erythrocyte sedimentation rate; functional status such as the Bath Ankylosing Spondylitis Functional Index; and general health status such as the Assessment of Spondyloarthritis International Society Health Index of the patients were recorded. C-reactive protein, erythrocyte sedimentation rate, platelet to lymphocyte ratio, neutrophil to lymphocyte ratio, monocyte to lymphocyte ratio, systemic immune inflammation index, systemic inflammation response index, and systemic inflammation aggregate index values were recorded. Patients were grouped as active and remission according to the Bath Ankylosing Spondylitis Disease Activity Index score and as inactive-low and high-very high disease activity according to the Ankylosing Spondylitis Disease Activity Score. The correlation of laboratory parameters with disease-related parameters was tested. RESULTS: The indexes were significantly higher in patients compared to controls (p<0.001, for platelet to lymphocyte ratio p=0.03). No significant differences existed in any blood cell-derived indexes among patient groups categorized by disease activity (p<0.05 for all). Systemic immune inflammation index was weakly correlated with Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ρ=0.197 and p=0.049) and Ankylosing Spondylitis Disease Activity Score-erythrocyte sedimentation rate (ρ=0.201 and p=0.045). Systemic immune inflammation index was not correlated with Bath Ankylosing Spondylitis Disease Activity Index, Bath Ankylosing Spondylitis Functional Index, and Assessment of Spondyloarthritis International Society Health Index. No correlation was found between other indexes and disease-related variables. Platelet to lymphocyte ratio, systemic immune inflammation index, systemic inflammation response index, and systemic inflammation aggregate index showed a weak positive correlation with C-reactive protein and erythrocyte sedimentation rate (ρ=0.200-0.381). CONCLUSION: Systemic immune inflammation index, systemic inflammation response index, and systemic inflammation aggregate index can be used to indicate systemic inflammatory burden in ankylosing spondylitis patients. However, these indexes are not effective in indicating patients' disease activity, general health status, and functional status.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

20citationsOpenAlex · cited_by_count (cache / database)

8 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2024 Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitorsCitations 11 · OpenAlex
  2. 2024 Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitorsCitations 11 · OpenAlex
  3. 2024 Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitorsCitations 11 · OpenAlex
  4. 2025 Novel inflammatory biomarkers for discriminating vascular involvement in Behçet’s syndrome: evaluating SII, SIRI, and NPARCitations 6 · OpenAlex
  5. 2025 Novel inflammatory biomarkers for discriminating vascular involvement in Behçet’s syndrome: evaluating SII, SIRI, and NPARCitations 6 · OpenAlex
  6. 2025 Novel inflammatory biomarkers for discriminating vascular involvement in Behçet’s syndrome: evaluating SII, SIRI, and NPARCitations 6 · OpenAlex
  7. 2025 Comparison of inflammatory markers in women experiencing both missed abortion and healthy pregnancy: A self-controlled case studyCitations 3 · OpenAlex
  8. 2025 Association between disease activity and HALP score in ankylosing spondylitis patientsCitations 2 · OpenAlex

Authors

5
  1. AYLİN SARIYILDIZ ÇUKUROVA ÜNİVERSİTESİ 1
  2. İLKE COŞKUN BENLİDAYI 2
  3. İPEK TÜRK 3
  4. ŞERİFE ŞEYDA ZENGİN ACEMOĞLU 4
  5. İLKER ÜNAL 5